Literature DB >> 24457416

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.

Dominik Sturm1, Sebastian Bender1, David T W Jones2, Peter Lichter3, Jacques Grill4, Oren Becher5, Cynthia Hawkins6, Jacek Majewski7, Chris Jones8, Joseph F Costello9, Antonio Iavarone10, Kenneth Aldape11, Cameron W Brennan12, Nada Jabado7, Stefan M Pfister13.   

Abstract

We have extended our understanding of the molecular biology that underlies adult glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents have remained a relatively under-investigated disease. The latest large-scale genomic and epigenomic profiling studies have yielded an unprecedented abundance of novel data and provided deeper insights into gliomagenesis across all age groups, which has highlighted key distinctions but also some commonalities. As we are on the verge of dissecting glioblastomas into meaningful biological subgroups, this Review summarizes the hallmark genetic alterations that are associated with distinct epigenetic features and patient characteristics in both paediatric and adult disease, and examines the complex interplay between the glioblastoma genome and epigenome.

Entities:  

Mesh:

Year:  2014        PMID: 24457416      PMCID: PMC4003223          DOI: 10.1038/nrc3655

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  223 in total

1.  Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.

Authors:  Elizabeth A Maher; Cameron Brennan; Patrick Y Wen; Laura Durso; Keith L Ligon; Aaron Richardson; Deepak Khatry; Bin Feng; Raktim Sinha; David N Louis; John Quackenbush; Peter McL Black; Lynda Chin; Ronald A DePinho
Journal:  Cancer Res       Date:  2006-11-17       Impact factor: 12.701

Review 2.  Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.

Authors:  M H A Jansen; D G van Vuurden; W P Vandertop; G J L Kaspers
Journal:  Cancer Treat Rev       Date:  2011-07-20       Impact factor: 12.111

3.  Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma.

Authors:  Michelle Monje; Siddhartha S Mitra; Morgan E Freret; Tal B Raveh; James Kim; Marilyn Masek; Joanne L Attema; Gordon Li; Terri Haddix; Michael S B Edwards; Paul G Fisher; Irving L Weissman; David H Rowitch; Hannes Vogel; Albert J Wong; Philip A Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-01       Impact factor: 11.205

4.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Authors:  M Esteller; S R Hamilton; P C Burger; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

5.  Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.

Authors:  Akiko Ohnishi; Hirofumi Sawa; Masumi Tsuda; Yutaka Sawamura; Tomoo Itoh; Yoshinobu Iwasaki; Kazuo Nagashima
Journal:  J Neuropathol Exp Neurol       Date:  2003-10       Impact factor: 3.685

6.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

Authors:  Kui-Ming Chan; Dong Fang; Haiyun Gan; Rintaro Hashizume; Chuanhe Yu; Mark Schroeder; Nalin Gupta; Sabine Mueller; C David James; Robert Jenkins; Jann Sarkaria; Zhiguo Zhang
Journal:  Genes Dev       Date:  2013-04-19       Impact factor: 11.361

7.  Transforming fusions of FGFR and TACC genes in human glioblastoma.

Authors:  Devendra Singh; Joseph Minhow Chan; Pietro Zoppoli; Francesco Niola; Ryan Sullivan; Angelica Castano; Eric Minwei Liu; Jonathan Reichel; Paola Porrati; Serena Pellegatta; Kunlong Qiu; Zhibo Gao; Michele Ceccarelli; Riccardo Riccardi; Daniel J Brat; Abhijit Guha; Ken Aldape; John G Golfinos; David Zagzag; Tom Mikkelsen; Gaetano Finocchiaro; Anna Lasorella; Raul Rabadan; Antonio Iavarone
Journal:  Science       Date:  2012-07-26       Impact factor: 47.728

8.  Incidence of gliomas by anatomic location.

Authors:  Suvi Larjavaara; Riitta Mäntylä; Tiina Salminen; Hannu Haapasalo; Jani Raitanen; Juha Jääskeläinen; Anssi Auvinen
Journal:  Neuro Oncol       Date:  2007-05-23       Impact factor: 12.300

9.  Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

Authors:  Dinorah Friedmann-Morvinski; Eric A Bushong; Eugene Ke; Yasushi Soda; Tomotoshi Marumoto; Oded Singer; Mark H Ellisman; Inder M Verma
Journal:  Science       Date:  2012-10-18       Impact factor: 47.728

10.  Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

Authors:  Henry S Friedman; Michael D Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James Vredenburgh; Jane Huang; Maoxia Zheng; Timothy Cloughesy
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

View more
  227 in total

1.  Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.

Authors:  Adam L Green; Shakti H Ramkissoon; Dilara McCauley; Kristen Jones; Jennifer A Perry; Jessie Hao-Ru Hsu; Lori A Ramkissoon; Cecile L Maire; Benjamin Hubbell-Engler; David S Knoff; Sharon Shacham; Keith L Ligon; Andrew L Kung
Journal:  Neuro Oncol       Date:  2014-11-02       Impact factor: 12.300

Review 2.  Molecular insights into pediatric brain tumors have the potential to transform therapy.

Authors:  Amar Gajjar; Stefan M Pfister; Michael D Taylor; Richard J Gilbertson
Journal:  Clin Cancer Res       Date:  2014-11-15       Impact factor: 12.531

3.  Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.

Authors:  Hideki Murata; Koji Yoshimoto; Ryusuke Hatae; Yojiro Akagi; Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Tetsuro Sayama; Koji Iihara
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

Review 4.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

5.  Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized Medicine.

Authors:  Célia Dupain; Anne C Harttrampf; Yannick Boursin; Manuel Lebeurrier; Windy Rondof; Guillaume Robert-Siegwald; Pierre Khoueiry; Birgit Geoerger; Liliane Massaad-Massade
Journal:  Mol Ther       Date:  2018-11-02       Impact factor: 11.454

Review 6.  Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.

Authors:  Philip Lee; Ben Murphy; Rickey Miller; Vivek Menon; Naren L Banik; Pierre Giglio; Scott M Lindhorst; Abhay K Varma; William A Vandergrift; Sunil J Patel; Arabinda Das
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

Review 7.  The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.

Authors:  Estelle Willems; Arnaud Lombard; Matthias Dedobbeleer; Nicolas Goffart; Bernard Rogister
Journal:  Target Oncol       Date:  2017-02       Impact factor: 4.493

Review 8.  Peptide vaccines for the treatment of glioblastoma.

Authors:  Adam M Swartz; Kristen A Batich; Peter E Fecci; John H Sampson
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

9.  Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Authors:  Kristian W Pajtler; Ji Wen; Martin Sill; Tong Lin; Wilda Orisme; Bo Tang; Jens-Martin Hübner; Vijay Ramaswamy; Sujuan Jia; James D Dalton; Kelly Haupfear; Hazel A Rogers; Chandanamali Punchihewa; Ryan Lee; John Easton; Gang Wu; Timothy A Ritzmann; Rebecca Chapman; Lukas Chavez; Fredrick A Boop; Paul Klimo; Noah D Sabin; Robert Ogg; Stephen C Mack; Brian D Freibaum; Hong Joo Kim; Hendrik Witt; David T W Jones; Baohan Vo; Amar Gajjar; Stan Pounds; Arzu Onar-Thomas; Martine F Roussel; Jinghui Zhang; J Paul Taylor; Thomas E Merchant; Richard Grundy; Ruth G Tatevossian; Michael D Taylor; Stefan M Pfister; Andrey Korshunov; Marcel Kool; David W Ellison
Journal:  Acta Neuropathol       Date:  2018-06-16       Impact factor: 17.088

10.  Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy.

Authors:  Jian Teng; Seyedali Hejazi; Christian E Badr; Bakhos A Tannous
Journal:  Stem Cells       Date:  2014-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.